EMPagliflozin After Aortic Valve Replacement

PHASE4RecruitingINTERVENTIONAL

Enrollment

205

Participants

Timeline

Start Date

February 14, 2024

Primary Completion Date

August 31, 2025

Study Completion Date

January 31, 2026

Conditions

Aortic Valve Stenosis

Interventions

DRUG

Empagliflozin

10 mg empagliflozin daily for six months

DRUG

Placebo

Placebo capsule once daily for six months

Trial Locations (1)

RECRUITING

University Hospital of Copenhagen, Rigshospitalet, Copenhagen

All Listed Sponsors

lead

Rigshospitalet, Denmark

OTHER